BioProtect Overview

  • Status
  • Private
  • Employees
  • 34
Employees
  • Latest Deal Type
  • Series D
  • Latest Deal Amount
  • $25M
Latest Deal Amount
  • Investors
  • 19

BioProtect General Information

Description

Developer of a pro-space balloon system designed to safely and temporarily separate the rectum from the prostate during prostate cancer radiation therapy. The company's system acts as a spacer for the protection of healthy tissues in patients receiving radiotherapy for prostate cancer, enabling healthcare institutions to dramatically decrease the probability of serious and chronic radiation side effects while improving biochemical tumor control.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Medical Supplies
Other Industries
Other Devices and Supplies
Primary Office
  • 8 Tsor Street
  • Tzur Yigal 4486200
  • Israel
+972 00-000-0000

BioProtect Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BioProtect Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC (Series D) 22-Sep-2020 $25M 000.00 000.00 Completed Generating Revenue
10. Accelerator/Incubator 01-Jan-2018 000.00 Completed Generating Revenue
9. Later Stage VC (Series C) 13-Apr-2017 00.000 000.00 0000 Completed Generating Revenue
8. Later Stage VC (Series B) 01-Jun-2016 00000 00.00 Completed Generating Revenue
7. Grant 01-Oct-2014 000 00.000 Completed Generating Revenue
6. Later Stage VC 15-Nov-2013 00.000 00.000 00.000 Completed Generating Revenue
5. Later Stage VC (Series A) 01-Dec-2012 00.00 00.000 00.000 Completed Generating Revenue
4. Later Stage VC (Series A) 12-Jun-2008 00000 00.000 00.000 Completed Generating Revenue
3. Early Stage VC (Series A) 01-Feb-2006 $700K $850K 00.000 Completed Generating Revenue
2. Seed Round 18-Oct-2004 $150K $150K Completed Startup
To view BioProtect’s complete valuation and funding history, request access »

BioProtect Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preferred C2 00,000 00.00 00.00 00 00.00 0.000
Preferred C1 000,000 000.00 000.00 00 000.00 00.000
Preferred B 0,000,000 00.00 00.00 00 00.00 00.000
Preferred A4 0,000 0000 0000 00 0000 0.000
Preferred A3 00,000 0000 0000 00 0000 0.000
Preferred A2 0,000 0000 0000 00 0000 0.000
Preferred A1 2,838 $350 $350 1x $350 0.18%
Preferred A 4,500 $141.52 $141.52 1x $141.52 0.26%
To view BioProtect’s complete cap table history, request access »

BioProtect Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a pro-space balloon system designed to safely and temporarily separate the rectum from the prostate during
Medical Supplies
Tzur Yigal, Israel
34 As of 2021
000.00
00.00 0000-00-00
00000000000 000.00

000000 0

o consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat
00000000000 0000000
Marlborough, MA
00000 As of 0000
00000
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BioProtect Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
000000 0000000000 Corporation Marlborough, MA 00000 00000 000000&0
You’re viewing 1 of 1 competitors. Get the full list »

BioProtect Executive Team (11)

Name Title Board Seat Contact Info
Gil Rosen Chief Executive Officer & Board Member
Shahar Shaked Chief Operating Officer and Vice President of Finance and Administration
Shaul Shohat Co-Founder & Chief Technology Officer
You’re viewing 3 of 11 executive team members. Get the full list »

BioProtect Board Members (12)

Name Representing Role Since
Assaf Dekel MD Self Board Member 000 0000
Eyal Lifschitz Peregrine Ventures Board Member 000 0000
Gennadiy Tolstobrov BioProtect Board Member 000 0000
Gil Rosen BioProtect Chief Executive Officer & Board Member 000 0000
Irit Yaniv MD Accelmed Ventures Chairwoman 000 0000
You’re viewing 5 of 12 board members. Get the full list »

BioProtect Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioProtect Investors (19)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Accelmed Ventures Venture Capital Minority 000 0000 000000 0
Almeda Ventures Venture Capital Minority 000 0000 000000 0
Consensus Business Group Asset Manager Minority 000 0000 000000 0
KB Investment Venture Capital Minority 000 0000 000000 0
Musea Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 19 investors. Get the full list »